AMETEK, Inc. is a leading global manufacturer of electronic instruments and electromechanical devices with annual sales of approximately $5 billion.
AMETEK has 18,000 colleagues at more than 150 operating locations, and a global network of sales, service and support locations in 30 countries around the world.
The AMETEK Growth Model combines its four growth strategies of Operational Excellence, Strategic Acquisitions, Global & Market Expansion, and New Product Development, with a disciplined focus on cash generation and capital deployment. By executing the AMETEK Growth Model, the company seeks to generate shareholder value by doubling earnings per share over the course of each business cycle.
AMETEK consists of two operating groups, both with highly-differentiated technology and leading positions in niche markets:
AMETEK has been publicly traded on the NYSE since 1930 and is a component of the S&P 500.
In this interview, we speak with Stanford's Gu Group about their newly developed metal nanocluster-based material that's advancing nanoscale 3D printing.
Professor Andre Nel
In this interview, AZoNano speaks with Professor Andre Nel about his involvement in innovative research describing the development of a 'glass bubble' nanocarrier that could help drug formulations access pancreatic cancer cells.
Jingang Li, Ph.D.
In this interview, AZoNano speaks with Jingang Li from the University of California, Berkley, who offers an introduction to the Nobel Prize-winning technology, Optical Tweezers.
The MiniCapt® Pro is a remote microbial air sampler that is ideal for the pharmaceutical manufacturing industry.
This product profile outlines the NanoRacer High-Speed AFM from Bruker JPK.
NMR spectroscopy is a characterization technique that is extensively used by chemical researchers.